RARA and cancer: In other BTB domain-containing fusion-positive cancers, such as PLZF/Retinoic Acid Receptor alpha (RAR alpha) that causes Acute Myeloid Leukemia (AML), disruption of the BTB domain also abrogates oligomer formation and fusion protein functions [19].